Agilent Technologies, Inc.

Equities

A

US00846U1016

Advanced Medical Equipment & Technology

Market Closed - Nyse Other stock markets 01:30:02 18/07/2024 am IST			5-day change	1st Jan Change
133.5 ^USD	-1.88%		+5.06%	-3.98%

10/07	Citigroup Upgrades Agilent Technologies to Buy From Neutral, Adjusts Price Target to $150 From $135	MT
02/07	Evercore ISI Raises Price Target on Agilent Technologies to $130 From $126, Maintains In Line Rating	MT

Agilent Technologies, Inc. (NYSE:A) acquired Luxcel Biosciences Ltd.

January 09, 2018

Agilent Technologies, Inc. (NYSE:A) acquired Luxcel Biosciences Ltd. on January 9, 2018. Following the acquisition, the Luxcel team will remain in Cork and form a dedicated sensor chemistries and bioassay solutions group within Agilent's Cell Analysis Division. Agilent Technologies, Inc. (NYSE:A) completed the acquisition of Luxcel Biosciences Ltd. on January 9, 2018.

Latest news about Agilent Technologies, Inc.

Citigroup Upgrades Agilent Technologies to Buy From Neutral, Adjusts Price Target to $150 From $135	10/07	MT
Evercore ISI Raises Price Target on Agilent Technologies to $130 From $126, Maintains In Line Rating	02/07	MT
Agilent Technologies, Inc Appoints Bret Dimarco as Senior Vice President and Chief Legal Officer and Secretary	01/07	CI
Agilent Technologies, Inc.(NYSE:A) dropped from Russell Midcap Growth Index	01/07	CI
Agilent Technologies, Inc.(NYSE:A) dropped from Russell 3000 Growth Index	01/07	CI
Agilent Technologies, Inc.(NYSE:A) dropped from Russell 3000E Growth Index	01/07	CI
Agilent Technologies, Inc.(NYSE:A) dropped from Russell 1000 Growth Index	01/07	CI
Agilent Technologies, Inc.(NYSE:A) dropped from Russell 1000 Growth-Defensive Index	01/07	CI
Wolfe Research Downgrades Agilent Technologies to Peer Perform From Outperform	27/06	MT
RareCyte, Inc. announced that it has received $20 million in funding from a group of investors	27/06	CI
Masimo Shareholder Politan Capital Campaigns for 2 More Board Seats	26/06	MT
Bristol Myers: ex-CEO of Agilent joins Board of Directors	19/06	CF
MGI Tech Co., Ltd. and SeqOne Partner to Advance End-To-End Genomic Analysis	17/06	CI
Agilent Technologies Insider Sold Shares Worth $1,999,262, According to a Recent SEC Filing	12/06	MT
Agilent Technologies Insider Sold Shares Worth $254,540, According to a Recent SEC Filing	05/06	MT
Agilent Technologies Seeks M&A	05/06	CI
Transcript : Agilent Technologies, Inc. Presents at Jefferies 2024 Global Healthcare Conference, Jun-05-2024 08:30 AM	05/06
Agilent Technologies, Inc. Is Introducing Two New Products At the 72Nd Asms Conference on Mass Spectrometry and Allied Topics	03/06	CI
Tranche Update on Agilent Technologies, Inc. (NYSE:A)'s Equity Buyback Plan announced on January 9, 2023.	03/06	CI
A new phase for the market	30/05
UBS Cuts Price Target on Agilent Technologies to $141 From $155, Keeps Neutral Rating	30/05	MT
Wolfe Research Adjusts Agilent Technologies' PT to $135 From $155	30/05	MT
Leerink Adjusts Price Target on Agilent Technologies to $135 From $150	30/05	MT
Stifel Adjusts Price Target on Agilent Technologies to $151 From $163	30/05	MT
JPMorgan Adjusts Price Target on Agilent Technologies to $155 From $165	30/05	MT

Chart Agilent Technologies, Inc.

Duration

Period

More charts

Company Profile

Agilent Technologies, Inc. specializes in the design, manufacturing and marketing of measurement instruments intended primarily for the communications, electronics, life sciences, and chemistry sectors. The activity is organized mainly around three families of products: - electronic measurement instruments; - bio-analytical measurement instruments: used to identify, quantify, and analyze the physical and biological properties of substances and products; - measurement instruments for semiconductors. Net sales break down by source of income between sales of products (73.9%) and services (26.1%). Net sales are distributed geographically as follows: the United States (40%), China (34.3%) and other (25.7%).

Sector

Advanced Medical Equipment & Technology

Calendar

22/08/2024 - Q3 2024 Earnings Release

Related indices

S&P 500

More about the company

Income Statement Evolution

More financial data

Ratings for Agilent Technologies, Inc.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

133.5 USD

Average target price

141 USD

Spread / Average Target

+5.64%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
AGILENT TECHNOLOGIES, INC.	-3.98%	38.95B
THERMO FISHER SCIENTIFIC	+4.57%	212B
DANAHER CORPORATION	+8.61%	186B
INTUITIVE SURGICAL, INC.	+26.34%	151B
BOSTON SCIENTIFIC CORPORATION	+33.90%	114B
SIEMENS HEALTHINEERS AG	+3.35%	65.57B
EDWARDS LIFESCIENCES CORPORATION	+14.50%	52.61B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	-3.30%	46.8B
GE HEALTHCARE TECHNOLOGIES INC.	+6.66%	37.64B
RESMED, INC.	+19.72%	30.25B

Other Advanced Medical Equipment & Technology